BPC-157

Body Protection Compound-157 · Bepecin · PL 14736

Rank#999
Tissue RepairCategory 2Phase IIResearchSubQIM

Popular for:Injury recovery, gut healing, tendon and ligament repair

201

Total Studies

44

Human Studies

Phase II

Evidence Level

Category 2

FDA Status

Overview

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protective protein found in human gastric juice. It is one of the most extensively studied healing peptides, with hundreds of animal studies demonstrating powerful tissue repair, gut healing, and anti-inflammatory properties.

**Originally developed for: **Gastrointestinal protection and healing. It was identified as a stable fragment of human gastric juice protein BPC, and initially studied for its cytoprotective effects on the GI tract, including protection against NSAID-induced damage and ulcers.

Mechanism of Action

BPC-157 works through multiple overlapping pathways. It upregulates VEGF (vascular endothelial growth factor) to promote angiogenesis and new blood vessel formation at injury sites. It modulates the nitric oxide (NO) system for vasodilation and GI protection. It activates the FAK-paxillin pathway to promote tendon fibroblast migration and healing. It reduces pro-inflammatory cytokines without causing immunosuppression and modulates dopaminergic D1/D2 receptor pathways with neuroprotective effects.

Key Research Benefits

Primary Benefits:

Accelerated tendon and ligament healing — improved biomechanical properties in rat Achilles tendon studies (Chang et al., 2011; Staresinic et al., 2003)
Gastrointestinal protection — heals ulcers, protects against NSAID-induced gut damage, beneficial for IBD and leaky gut (Sikiric et al., 2006)
Muscle and bone healing — promotes faster recovery from crush injuries and fractures (Novinscak et al., 2008)
Angiogenesis — promotes new blood vessel formation at injury sites via VEGF upregulation (Hsieh et al., 2016)

Secondary/Emerging Benefits:

Neuroprotection — protects against dopaminergic neurotoxins, potential for traumatic brain injury recovery (Vukojevic et al., 2020)
Cardioprotection — studies show protective effects in heart failure, arrhythmias, and thrombosis models
Liver protection — prevented and reversed alcohol-induced liver damage in rat studies (Sikiric et al.)
Anti-depressant-like effects — modulates dopamine and serotonin systems

Clinical Evidence Summary

Research Pipeline

Preclinical
Animal
Phase I
Phase II
Phase III
Approved

201

Total Studies

44

Human Studies

- Sikiric et al. (2006, 2010, 2014) — Extensive body of work across 100+ studies showing tissue repair, GI protection, and anti-inflammatory effects in rats. The foundational research for BPC-157.

- Chang et al. (2011, 2014) — Demonstrated BPC-157 promotes tendon healing via outgrowth, cell survival, cell migration, and upregulation of growth hormone receptors in tendon fibroblasts.

- Hsieh et al. (2016) — Showed BPC-157's pro-angiogenic effects are mediated by VEGFR2 activation.

- Vukojevic et al. (2020) — Demonstrated protective effects against hippocampal ischemia/reperfusion injuries in rats.

- PMC systematic review (2024) — Comprehensive orthopaedic sports medicine review synthesizing all available BPC-157 literature.

> Clinical trial status: No completed human clinical trials as of 2026. All evidence is from animal studies (primarily rats). Despite this, it is increasingly used by clinicians and athletes.

Key Studies / PubMed References

201 studies found on PubMed · showing top 25 by relevance

View all on PubMed

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Review

Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026

PMID: 41490200

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.

Meta-Analysis

Vasireddi N, Hahamyan H, Salata MJ, et al. · HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025

PMID: 40756949

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

Human Study

Lee E, Burgess K · Alternative therapies in health and medicine · 2025

PMID: 40131143

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.

Review

McGuire FP, Martinez R, Lenz A, et al. · Current reviews in musculoskeletal medicine · 2025

PMID: 40789979

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

Review

Sikiric P, Seiwerth S, Skrtic A, et al. · Pharmaceuticals (Basel, Switzerland) · 2025

PMID: 40573323

Side Effects & Safety

Common Side Effects:

Mild nausea (more common with oral dosing)
Brief lightheadedness after injection
Injection site redness/irritation
Mild fatigue (uncommon)

Rare but Serious Risks:

Theoretical concern with angiogenesis: promoting blood vessel growth could theoretically accelerate tumor growth in someone with pre-existing cancer. No evidence of this occurring, but it's the primary safety concern discussed in the literature.
No lethal dose (LD50) was found even at very high concentrations in toxicology studies

> Contraindications: Individuals with active cancer or a history of cancer should avoid BPC-157 due to its angiogenic properties. Not recommended during pregnancy or breastfeeding. No known drug interactions, but caution is warranted when combining with other peptides that affect the NO system.

Known Interactions

No curated interaction entry is live for BPC-157 yet.

Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.

Frequently Asked Questions

Research Disclaimer

This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. BPC-157 is not approved by the FDA for human therapeutic use. Always consult a qualified healthcare professional before making any health-related decisions. The studies referenced are linked to their original PubMed sources for verification.